PATH | VRL
Menu

A Case Study Using the United Republic of Tanzania: Costing Nationwide HPV Vaccine Delivery Using the WHO Cervical Cancer Prevention and Control Costing Tool

This article, published in BMC Medicine, reports on a study to determine the cost of establishing a human papillomavirus (HPV) vaccine program that delivers three doses of vaccine to girls at schools via phased national introduction in Tanzania. It uses the World Health Organization’s Cervical Cancer Prevention and Control Costing Tool, which was developed to assist low- and middle-income countries with planning and costing their nationwide HPV vaccination programs. The authors conclude that when countries expand their immunization schedules with new vaccines such as the HPV vaccine, governments should plan ahead for initial costs as well as incremental system costs.

Author: Hutubessy R, Levin A, Wang S, et al.

Published: 2012

» Visit web page (English)

(Located at www.biomedcentral.com)

Citation: Hutubessy R, Levin A, Wang S, et al. A Case Study Using the United Republic of Tanzania: Costing Nationwide HPV Vaccine Delivery Using the WHO Cervical Cancer Prevention and Control Costing Tool. BMC Medicine. 2012;10:136.

Resource types: Peer-reviewed journal

Diseases/vaccines: Human papillomavirus (HPV)

Topics: Introduction and service delivery, Immunization financing, Disease/vaccine specific information

Regions: Africa